Sevoflurane

Non-dispersive Infrared (NDIR) Market worth $965 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 2, 2024
Carbon, Condensate, Gas, Temperature, Health, PLC, Transport, Isoflurane, HVAC, Sevoflurane, Lidar, Oxygen, Honeywell, OTDR, Capnography, SCADA, Row, Anesthesia, Controller, Security alarm, Desflurane, Air pollution, Region, Oil, Thermography, Environmental monitoring, Textile, COVID-19, MSA, Digital, VOC, Yokogawa Electric, Amphenol, Carbon dioxide, Brownfield land, Nitrous oxide, Natural gas, Carbon monoxide, Mining, Acoustic, Environment, Optical fiber, Volatile organic compound, Plastic, Atmosphere, Water, Power, Hardware

Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.

Key Points: 
  • Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.
  • Monitoring of refrigerant gases, capnography etc are likely to boost NDIR market.
  • NDIR market for VOCs to hold high market share during the forecast period.
  • Industrial & Manufacturing segment by vertical in NDIR industry to hold high market share during the forecast period.

Non-dispersive Infrared (NDIR) Market worth $965 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, April 2, 2024
Carbon, Condensate, Gas, Temperature, Health, PLC, Transport, Isoflurane, HVAC, Sevoflurane, Lidar, Oxygen, Honeywell, OTDR, Capnography, SCADA, Row, Anesthesia, Controller, Security alarm, Desflurane, Air pollution, Region, Oil, Thermography, Environmental monitoring, Textile, COVID-19, MSA, Digital, VOC, Yokogawa Electric, Amphenol, Carbon dioxide, Brownfield land, Nitrous oxide, Natural gas, Carbon monoxide, Mining, Acoustic, Environment, Optical fiber, Volatile organic compound, Plastic, Atmosphere, Water, Power, Hardware

Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.

Key Points: 
  • Based on application type, the NDIR market for monitoring applications is expected to hold the highest market share during the forecast period.
  • Monitoring of refrigerant gases, capnography etc are likely to boost NDIR market.
  • NDIR market for VOCs to hold high market share during the forecast period.
  • Industrial & Manufacturing segment by vertical in NDIR industry to hold high market share during the forecast period.

Piramal Pharma Limited Announces Consolidated Results for Q1FY24

Retrieved on: 
Thursday, August 3, 2023
Ciba-Geigy Canada Ltd v Apotex Inc, API, ICH, Prestige Consumer Healthcare, INR, EBITDA, CDMO, Yoy, ADC, ESG, Growth, CHG, Fine chemical, Sevoflurane

81, Record Date of August 2, 2023 and Entitlement Ratio of 5:46

Key Points: 
  • 81, Record Date of August 2, 2023 and Entitlement Ratio of 5:46
    Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We had a positive start to the new financial year with healthy revenue growth and improvement in our EBITDA margins.
  • Our CDMO business is also witnessing continued order inflows, especially for our differentiated offerings and innovation related work.
  • Our Inhalation Anesthesia portfolio is seeing a healthy demand and our India Consumer Healthcare business is delivering good growth driven by power brands.
  • We believe in the growth potential of our business and are accordingly executing on our strategic priorities to create shareholder value.

Piramal Pharma Limited Announces Consolidated Results for Q1FY24

Retrieved on: 
Thursday, August 3, 2023
Ciba-Geigy Canada Ltd v Apotex Inc, API, ICH, Prestige Consumer Healthcare, INR, EBITDA, CDMO, Yoy, ADC, ESG, Growth, CHG, Fine chemical, Sevoflurane

81, Record Date of August 2, 2023 and Entitlement Ratio of 5:46

Key Points: 
  • 81, Record Date of August 2, 2023 and Entitlement Ratio of 5:46
    Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We had a positive start to the new financial year with healthy revenue growth and improvement in our EBITDA margins.
  • Our CDMO business is also witnessing continued order inflows, especially for our differentiated offerings and innovation related work.
  • Our Inhalation Anesthesia portfolio is seeing a healthy demand and our India Consumer Healthcare business is delivering good growth driven by power brands.
  • We believe in the growth potential of our business and are accordingly executing on our strategic priorities to create shareholder value.

Global Inhalation Anesthesia Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts

Retrieved on: 
Friday, January 20, 2023
Piramal Group, Sevoflurane, Hypoventilation, Desflurane, Merck Group, COVID-19, Inhalation, Baxter International, Anesthesia, Isoflurane, Prevalence, R, Hospital, Patient, Operating, AbbVie, Nitrous oxide, Asthma, Anesthetic, Research, Semiconductor, Dentistry, Pharmaceutical industry, Potash, Growth

DUBLIN, Jan. 20, 2023 /PRNewswire/ -- The "Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 20, 2023 /PRNewswire/ -- The "Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global inhalation anesthesia market size reached US$ 1.5 Billion in 2021.
  • Inhalation anesthesia refers to the anesthetic medications that are induced for maintaining the levels of general anesthesia and sedation in the body during surgery.
  • What is the structure of the global inhalation anesthesia market and who are the key players?

Insights on the Inhalation Anesthesia Global Market to 2027 - Increasing Prevalence of Chronic Medical Disorders Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 17, 2023
Health, Pharmaceutical, Hospital, Anesthetic, Inhalation, R, COVID-19, Desflurane, Nitrous oxide, Sevoflurane, Growth, Anesthesia, Patient, Prevalence, Paola Lattus, Research, Asthma, Isoflurane, Hypoventilation, Pharmaceutical industry, Dentistry

Inhalation anesthesia refers to the anesthetic medications that are induced for maintaining the levels of general anesthesia and sedation in the body during surgery.

Key Points: 
  • Inhalation anesthesia refers to the anesthetic medications that are induced for maintaining the levels of general anesthesia and sedation in the body during surgery.
  • Some of the commonly used inhalation anesthetics include nitrous oxide, desflurane, isoflurane and sevoflurane.
  • The increasing prevalence of chronic medical disorders requiring surgical treatments is one of the key factors driving the growth of the market.
  • The publisher provides an analysis of the key trends in each sub-segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country level from 2022-2027.

Global Inhalation Anesthetics Market to Reach $1.5 Billion by 2027 at a CAGR of 3.7% - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022
Medical Devices, Hospitals, Health, Health Technology, Medical Supplies, Desflurane, Growth, Sevoflurane, Anesthesia, Anesthetic, Inhalation, COVID-19, Video game

In the changed post COVID-19 business landscape, the global market for Inhalation Anesthetics estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 3.7% over the analysis period 2020-2027.

Key Points: 
  • In the changed post COVID-19 business landscape, the global market for Inhalation Anesthetics estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 3.7% over the analysis period 2020-2027.
  • Sevoflurane, one of the segments analyzed in the report, is projected to record a 3.6% CAGR and reach US$906.9 Million by the end of the analysis period.
  • China, the world's second largest economy, is forecast to reach a projected market size of US$273.6 Million by the year 2027 trailing a CAGR of 3.4% over the analysis period 2020 to 2027.
  • In the global Nitrous Oxide segment, USA, Canada, Japan, China and Europe will drive the 3.4% CAGR estimated for this segment.

Inhalation Anesthesia Global Market Report 2022: Increased Safety for Geriatric Patients Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 27, 2022
General Health, Seniors, Consumer, Health, Pharmaceutical, Sevoflurane, Muscle, Dermatology, Growth, Vecuronium bromide, Anesthesia, Blood, Acquisition, Isoflurane, Patient, Dental care, Compliance, Population, Injection, Nitrous oxide, Ageing, Dechra Pharmaceuticals, Hospital, Maintenance, United Nations, Pain management, Degenerative disease, Therapy, Endocrinology, Ophthalmology, Desflurane, Asia-Pacific, Dentistry, Pharmaceutical industry

The "Inhalation Anesthesia Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Inhalation Anesthesia Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • North America was the largest region in the inhalation anesthesia market in 2021.
  • The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia during the forecast period.

Global Sevoflurane Market Report to 2030 - Size, Share, Outlook and Opportunity Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022
Health, General Health, Digital technology, FDA, GE Healthcare, Decision-making, PMA, Society, Marketing, Sevoflurane, Growth, Application, Industry, Region, Market share, US, Baxter International, Association, Face, Control, Anesthesia, Food, CAGR, Desflurane, Technology, Anesthetic, Maintenance, Regulation of tobacco by the U.S. Food and Drug Administration, Baxter, Renewable energy, Pharmaceutical industry, Abdominoplasty

The "Sevoflurane Market, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sevoflurane Market, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • This report provides an in-depth analysis of global sevoflurane market, provides market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year.
  • Market players are focused on launching new technology to help delivery of anesthesia through inhalers, this could contribute to the growth of the global sevoflurane market over the forecast period.
  • Increasing number of aesthetic surgeries requiring anesthesia, is expected to drive the growth of global sevoflurane market.

Disruptive Mobile Technology Advances Military Medical Training

Retrieved on: 
Tuesday, April 26, 2022
Ventilation, CEO, Vital signs, Simulation, Suction, Defense Health Agency, ISO, Learning, Thornhill, Cardiff, SLC, Technology, Physiology, Health, University, Capillary, Sevoflurane, MADM, Central Florida, Institute for Simulation and Training, Anesthesia, Defense, Institute, Time, Knowledge, Satellite navigation device, Medical device

DENVER, April 26, 2022 /PRNewswire-PRWeb/ -- Mobile learning innovator Allogy announces the launch of a new, easy-to-use mobile training application for military and other medical professionals who use portable lifesaving systems MOVES® SLC™ and MADM™ by Thornhill Medical.

Key Points: 
  • New mobile training app for Thornhill's MOVES SLC & MADM medical devices ensures 24/7 performance support to improve military readiness and achieve better outcomes.
  • DENVER, April 26, 2022 /PRNewswire-PRWeb/ -- Mobile learning innovator Allogy announces the launch of a new, easy-to-use mobile training application for military and other medical professionals who use portable lifesaving systems MOVES SLC and MADM by Thornhill Medical.
  • The new MOVES SLC & MADM Training application supplements Thornhill Medical's suite of in-person training experiences and on-demand online materials.
  • "Thanks to Allogy's efforts, the MOVES SLC & MADM mobile app ensures that military medical professionals have the information they need to deploy these systems successfully and improve patient care," says Madeline Cowie, Product Manager at Thornhill Medical.